Mar 21, 2026 by Jeremy BowmanThe Iran War Just Triggered a Bigger Energy Shock Than the 1970s Oil Crisis. What It Means for Your Portfolio.The war will likely continue to roil markets.
Mar 21, 2026 by Jeremy BowmanGoldman Sachs Just Sounded the Alarm on Private Credit. Here Are 2 Things Investors Need to Know.A crisis could be building in the private credit market.
Mar 21, 2026 by Prosper Junior BakinyIs This Stock a Buy on the Dip?This company has a habit of beating the market over long periods.
Mar 21, 2026 by Jonathan PoncianoThis $8.9 Million Buy Targets a Stock Down 68% With $322 Million in CashBiohaven develops clinical-stage therapies for neurological and immunoscience disorders, with no commercialized products to date.
Mar 21, 2026 by Jonathan PoncianoThis New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround StoryThis biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.
Mar 21, 2026 by Katie BrockmanWhat Happens to Your Investments If the Stock Market Crashes?There's good news and bad news for investors right now.
Mar 21, 2026 by Jonathan PoncianoThis $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug LaunchCogent Biosciences develops targeted therapies for genetically defined diseases, focusing on precision medicine for rare cancers.
Mar 21, 2026 by Joe TenebrusoWhy Scholastic Stock Climbed This WeekThe world's largest publisher of children's books is buying back a large swath of its shares.
Mar 21, 2026 by Jonathan PoncianoWhy This $18 Million Sale Might Signal a Shift as a China Tech Bet Falls 34%This China-based tech firm links employers and job seekers through its digital recruitment platform serving a broad labor market.
Mar 21, 2026 by Ryan VanzoShould Tesla Be Worried About Rivian?Tesla will face new competition next month.
Mar 21, 2026 by Neil PatelIs Apple Stock Going to $500? Here's What Has to Happen.After an impressive 953% trailing-10-year total return, investors are ready to tackle the next milestone.
Mar 21, 2026 by Parkev Tatevosian, CFAIs Micron the Next Nvidia?Micron is experiencing similar sharp revenue growth to Nvidia during the early months following the launch of ChatGPT.
Mar 21, 2026 by Parkev Tatevosian, CFAReddit Stock is Crashing: Is This a Generational Buying Opportunity?Social media companies other than Meta Platforms are struggling to gain investor traction.
Mar 21, 2026 by Jonathan PoncianoThis Biotech Was Quietly Bought Before a $58 Per Share TakeoutThis clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials.
Mar 21, 2026 by Parkev Tatevosian, CFAWhy Is SoFi Stock Crashing, and Should You Buy the Dip?This financial technology stock is struggling to shift investor sentiment.
Mar 21, 2026 by Prosper Junior BakinyIs This Stock a Buy on the Dip?This company has a habit of beating the market over long periods.
Mar 21, 2026 by Jonathan PoncianoHigh-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest HoldingThis biotechnology firm develops precision therapies for rare, genetically defined diseases, with a focus on targeted cancer treatments.
Mar 21, 2026 by Seena HassounaBristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
Mar 21, 2026 by Lawrence NgaUber's Advertising Business May Be Bigger Than Investors ThinkUber is best known for moving people and delivering food. However, something small but potentially profitable is growing at the company.
Mar 21, 2026 by Jonathan PoncianoThis Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should KnowThis clinical-stage biotech develops antibody therapies for thyroid eye disease, advancing multiple candidates through its R&D pipeline.
Mar 21, 2026 by Jonathan PoncianoThis Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should KnowThis clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients, targeting unmet needs in oncology treatment.
Mar 21, 2026 by James HiresThis Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026Small modular reactors are shaping up to be one of the biggest trends in nuclear power and BWX Technologies is one of the best ways to play it.
Mar 21, 2026 by Adam LevyBefore Retiring, Warren Buffett Left Investors With a $373 Billion Warning. Here's What History Says the Stock Market Will Do Next.Buffett's actions suggest that we could be knee-deep in investment opportunities soon.
